[1]
Y. Sieza, I. Di Camilo, L. Mazziotta, M. Archuby, M. Riva, and L. Orellano, “Distribution of JAK2, MPL and CALR mutations in patients with suspected Phi negative myeloproliferative neoplasms from Buenos Aires public hospitals”, RH, vol. 22, no. 2, pp. 151–156, Jan. 2019.